FinVector is a leading brand in the field of viral-based gene therapy manufacturing and product development. Powered by science and driven by collaboration, FinVector is committed to improving the lives of individuals with chronic health conditions. Our state-of-the-art cGMP manufacturing facility, located in Savilahti, Kuopio, Finland, is surrounded by breathtaking lakes and forests, providing an exceptional work environment and quality of life.

With international recognition as a pioneer in Viral-Based Gene Therapy, FinVector produces groundbreaking treatments for Non-Muscle Invasive Bladder Cancer, offering hope to countless patients worldwide. Our dedicated team of over 400 highly skilled professionals, recruited from across the globe, work together to excel in scientific manufacturing and deliver viral-based gene therapy products with the highest standards of safety and efficacy. At FinVector, we prioritize people.

We believe that our success lies within our employees and their unwavering dedication to their work and the well-being of others. As a people-first company, we foster a friendly, supportive, and well-structured environment that promotes both professional and personal growth. Join us in the fight against cancer and be part of a passionate team that develops life-saving therapies.

Contact us today to learn more about our brand and explore career opportunities with FinVector